Basit öğe kaydını göster

dc.contributor.authorDogu, Gamze G.
dc.contributor.authorKargi, Aysegul
dc.contributor.authorTanrıverdi, Özgür
dc.contributor.authorYaren, Arzu
dc.contributor.authorDemiray, Gokcen
dc.contributor.authorTaskoylu, Burcu Y.
dc.contributor.authorErgin, Ahmet
dc.date.accessioned2020-11-20T16:18:43Z
dc.date.available2020-11-20T16:18:43Z
dc.date.issued2014
dc.identifier.issn1306-133X
dc.identifier.urihttps://doi.org/10.4999/uhod.12008
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3624
dc.descriptionWOS: 000333944000007en_US
dc.description.abstractA study was designed to evaluate the frequency of complementary/alternative therapy (CAM) knowledge and usage in cancer patients. A 23-item survey questionnaire was administered to 494 patients who received chemotherapy in the medical oncology department of three hospitals between June 2011 and December 2011. After giving written informed consent, patients completed a self-administered questionnaire. Differences among participants were assessed by using the SPSS 17.0 software. Of the 494 patients, 48% had heard of CAM, and 23.5% had used at least one CAM model. Herbs and vitamins were the most frequently used approach (82.2%). The most commonly used herb was the stinging nettle (55.5%). Marital status (p=0.003), educational status (p<0.001), monthly income (p<0.001), knowledge about disease (p<0.001), family history of comorbidity (p<0.012), and place of residence (0.004) were statistically significant for knowledge about CAM. However, marital status (p<0.001), comorbidity (p=0.004), educational status (p=0.006), family history of comorbidity (p=0.008), and family history of cancer (p=0.03) were statistically significant for CAM use. Logistic regression analysis showed that educational status (p=0.015), high monthly income (p=0.03), knowledge about disease (p=0.005), and a family history of comorbidity (p=0.005) were statistically significant for knowledge about CAM. Otherwise, only marital status (p<0.001) and comorbidity (p=0.04) were determined as independent factors for CAM use. Health professionals should routinely ask their patients about CAM use and discuss the reasons and outcomes of use. Randomized clinical trials are needed to determine possible risks and benefits associated with CAM use.en_US
dc.item-language.isoengen_US
dc.publisherAkad Doktorlar Yayinevien_US
dc.item-rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCanceren_US
dc.subjectComplementary and Alternative Medicineen_US
dc.titleComplementary/Alternative Medicine Experience in Cancer Patients: A Questionnaire-Based Surveyen_US
dc.item-typearticleen_US
dc.contributor.departmenten_US
dc.contributor.departmentTemp[Dogu, Gamze G.; Yaren, Arzu; Demiray, Gokcen; Taskoylu, Burcu Y.] Pamukkale Univ, Fac Med, Dept Med Oncol, TR-20200 Denizli, Turkey -- [Kargi, Aysegul] Denizli State Hosp, Div Med Oncol, Denizli, Turkey -- [Tanriverdi, Ozgur] Mugla Univ, Fac Med, Dept Med Oncol, Mugla, Turkey -- [Ergin, Ahmet] Pamukkale Univ, Fac Med, Dept Publ Hlth, TR-20200 Denizli, Turkeyen_US
dc.identifier.doi10.4999/uhod.12008
dc.identifier.volume24en_US
dc.identifier.issue1en_US
dc.identifier.startpage45en_US
dc.identifier.endpage53en_US
dc.relation.journalUhod-Uluslararasi Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster